Machine learning for adverse event prediction in outpatient parenteral antimicrobial therapy: a scoping review

被引:0
|
作者
Challener, Douglas W. [1 ]
Fida, Madiha [1 ]
Martin, Peter [2 ]
Rivera, Christina G. [3 ]
Virk, Abinash [1 ]
Walker, Lorne W. [4 ,5 ]
机构
[1] Mayo Clin, Div Publ Hlth Infect Dis & Occupat Med, 200 First St SW, Rochester, MN 55905 USA
[2] Mayo Clin, Kern Ctr Sci Hlth Care Delivery, Rochester, MN USA
[3] Mayo Clin, Dept Pharm, Rochester, MN USA
[4] Oregon Hlth & Sci Univ, Div Pediat Infect Dis, Portland, OR USA
[5] Oregon Hlth & Sci Univ, Dept Med Informat & Clin Epidemiol, Portland, OR USA
关键词
ANTIBIOTIC-THERAPY; RISK-FACTORS; HEALTH-CARE; VANCOMYCIN; INFUSION; READMISSIONS; DAPTOMYCIN; MODEL; OPAT;
D O I
10.1093/jac/dkae340
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objective This study aimed to conduct a scoping review of machine learning (ML) techniques in outpatient parenteral antimicrobial therapy (OPAT) for predicting adverse outcomes and to evaluate their validation, implementation and potential barriers to adoption.Materials and methods This scoping review included studies applying ML algorithms to adult OPAT patients, covering techniques from logistic regression to neural networks. Outcomes considered were medication intolerance, toxicity, catheter complications, hospital readmission and patient deterioration. A comprehensive search was conducted across databases including Cochrane Central, Cochrane Reviews, Embase, Ovid MEDLINE and Scopus, from 1 January 2000 to 1 January 2024.Results Thirty-two studies met the inclusion criteria, with the majority being single-centre experiences primarily from North America. Most studies focused on developing new ML models to predict outcomes such as hospital readmissions and medication-related complications. However, there was very little reporting on the performance characteristics of these models, such as specificity, sensitivity and C-statistics. There was a lack of multi-centre or cross-centre validation, limiting generalizability. Few studies advanced beyond traditional logistic regression models, and integration into clinical practice remains limited.Discussion ML shows promise for enhancing OPAT outcomes by predicting adverse events and enabling pre-emptive interventions. Despite this potential, significant gaps exist in development, validation and practical implementation. Barriers include the need for representative data sets and broadly applicable, validated models.Conclusion Future research should address these barriers to fully leverage ML's potential in optimizing OPAT care and patient safety. Models must deliver timely, accurate and actionable insights to improve adverse event prediction and prevention in OPAT settings.
引用
收藏
页数:8
相关论文
共 50 条
  • [41] Recent Updates in Antimicrobial Stewardship in Outpatient Parenteral Antimicrobial Therapy
    Monica V. Mahoney
    Lindsey M. Childs-Kean
    Parisa Khan
    Christina G. Rivera
    Ryan W. Stevens
    Keenan L. Ryan
    Current Infectious Disease Reports, 2021, 23
  • [42] Antimicrobial Agents and Catheter Complications in Outpatient Parenteral Antimicrobial Therapy
    Keller, Sara C.
    Dzintars, Kathryn
    Gorski, Lisa A.
    Williams, Deborah
    Cosgrove, Sara E.
    PHARMACOTHERAPY, 2018, 38 (04): : 476 - 481
  • [43] Outpatient parenteral antimicrobial therapy in pediatrics: the role of antimicrobial stewardship
    Trisno, Daniel J.
    Puckett, Lauren
    Jensen, Alexandria
    Schwenk, Hayden T.
    ANTIMICROBIAL STEWARDSHIP & HEALTHCARE EPIDEMIOLOGY, 2024, 4 (01):
  • [44] Barriers and facilitators for the implementation and expansion of outpatient parenteral antimicrobial therapy: a systematic review
    Mohammed, S. A.
    Cotta, M. O.
    Assefa, G. M.
    Erku, D.
    Sime, F.
    JOURNAL OF HOSPITAL INFECTION, 2024, 147 : 1 - 16
  • [45] Routine Outpatient Parenteral Antimicrobial Therapy Clinic Review Minimizes Inpatient Readmission
    Marks, Michael
    Morris-Jones, Stephen
    Logan, Sarah
    Pollara, Gabriele
    CLINICAL INFECTIOUS DISEASES, 2020, 71 (10) : 2771 - 2773
  • [46] Serious Adverse Events and Laboratory Monitoring Regimens for Outpatient Parenteral Antimicrobial Therapy With Cefazolin and Ceftriaxone
    Sunagawa, Shawnalyn W.
    Arduser, Sarah
    Miller, Molly M.
    Lyden, Elizabeth
    LeMaster, Melissa
    Cortes-Penfield, Nicolas
    Hankins, Richard J.
    Bergman, Scott J.
    Alexander, Bryan T.
    OPEN FORUM INFECTIOUS DISEASES, 2023, 10 (12):
  • [47] Adverse events among renal transplant recipients receiving outpatient parenteral antimicrobial infusion therapy
    Farry, J. K.
    Miles, C. D.
    Collins, C. D.
    Malani, P. N.
    TRANSPLANT INFECTIOUS DISEASE, 2009, 11 (03) : 284 - 285
  • [48] Patient outcomes following home-based outpatient parenteral antimicrobial therapy and facility-based outpatient parenteral antimicrobial therapy: a systematic review and meta-analysis
    Hasegawa, Shinya
    Tholany, Joseph
    Healy, Heather
    Suzuki, Hiroyuki
    ANTIMICROBIAL STEWARDSHIP & HEALTHCARE EPIDEMIOLOGY, 2023, 3 (01):
  • [49] The use, appropriateness and outcomes of outpatient parenteral antimicrobial therapy
    Hodgson, Kate A.
    Huynh, Julie
    Ibrahim, Laila F.
    Sacks, Bronwyn
    Golshevsky, Daniel
    Layley, Michael
    Spagnolo, Mark
    Raymundo, Chin-Mae
    Bryant, Penelope A.
    ARCHIVES OF DISEASE IN CHILDHOOD, 2016, 101 (10) : 886 - 893
  • [50] Outpatient Parenteral Antimicrobial Therapy in Pediatric Medicaid Enrollees
    Goldman, Jennifer L.
    Richardson, Troy
    Newland, Jason G.
    Lee, Brian
    Gerber, Jeffrey S.
    Hall, Matt
    Kronman, Matthew
    Hersh, Adam L.
    JOURNAL OF THE PEDIATRIC INFECTIOUS DISEASES SOCIETY, 2017, 6 (01) : 65 - 71